2025-09-11 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the data you provided. I'll follow your requested format.

## Colgate-Palmolive (CL) Stock Analysis

**0) Executive Summary**

Colgate-Palmolive (CL) is a consumer staples company underperforming the S&P 500 (VOO) in terms of cumulative returns. Recent price action suggests a slight downward trend. While analyst ratings are generally positive, the company's expected return is very negative. Financial performance shows stable revenue and high profit margins, but ROE fluctuates significantly.

**1) Performance vs. S&P 500 (VOO)**

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co
*   **Description:** Colgate-Palmolive is a global consumer products company that specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
*   **CL Cumulative Return:** 11.79%
*   **VOO Cumulative Return:** 39.61%
*   **Spread (Deviation):**
    *   Current: -88.4
    *   Range: Max 7.9, Min -91.8
    *   Relative Deviation: 3.4
    *   **Interpretation:** CL has significantly underperformed VOO. The relative deviation suggests that the current underperformance is near the lower end of its historical range relative to VOO.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
| :----------- | :------ | :------ | :----- | :--- | :----- |
| 2015-2017  | 13.0%   | 4.5%    | 13.0%  | 1.0  | 60.2  |
| 2016-2018  | -11.0%  | 65.2%   | -11.0% | 1.0  | 47.5  |
| 2017-2019  | 7.0%    | 65.2%   | 7.0%   | 1.0  | 54.9  |
| 2018-2020  | 18.0%   | 65.2%   | 18.0%  | 1.0  | 68.2  |
| 2019-2021  | 30.0%   | 58.6%   | 29.0%  | 0.0  | 68.1  |
| 2020-2022  | 7.0%    | 69.0%   | 18.0%  | -0.0 | 62.9  |
| 2021-2023  | 6.0%    | 69.0%   | -4.0%  | -0.0 | 63.6  |
| 2022-2024  | 13.0%   | 69.0%   | -17.0% | -0.0 | 72.5  |
| 2023-2025  | -1.0%   | 70.6%   | -47.0% | 0.0  | 67.2  |

*   **Analysis:**  The provided data shows a declining Alpha over the more recent periods, indicating diminishing outperformance (or increasing underperformance) relative to the market. Beta is generally close to 0, suggesting low correlation with the market. The negative Alpha values in recent years highlight potential issues with CL's performance compared to its peers or the overall market.

**2) Recent Price Action**

*   **Current Price:** 84.28
*   **Last Market Data:** {'price': 83.2, 'previousClose': 84.28, 'change': -1.28}
*   **5-Day Moving Average:** 84.216
*   **20-Day Moving Average:** 84.7025
*   **60-Day Moving Average:** 86.936

*   **Analysis:** The price is below all moving averages, suggesting a short-term downward trend. The recent price drop (Last-market change of -1.28) indicates some selling pressure.

**3) Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3261 (Low Risk)
*   **RSI:** 40.64 (Bearish)
*   **PPO:** 0.1296 (Bullish)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (3 shares - Safe - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** 3.4 (Positive, Short-term Increase)
*   **Expected Return:** -1028.9%

*   **Analysis:**
    *   MRI indicates low market risk, which is generally positive.
    *   The RSI is below 50, suggesting the stock is not overbought and may have room to fall further.
    *   PPO is above 0, suggesting a positive trend
    *   The negative Expected Return is concerning and suggests very poor future performance relative to the S&P 500.
    *   The Hybrid Signal suggests a buy signal based on current indicators, while also emphasizing safety due to the low MRI.
    *   The negative `{'price': 83.2, 'previousClose': 84.28, 'change': -1.28}` suggests that the current price move may be more significant and may be a short-term issue.

**4) Recent News & Significant Events**

*   **Positive:**
    *   [2025-09-08] Here's How You Can Earn $100 In Passive Income By Investing In Colgate-Palmolive Stock (Benzinga)
    *   [2025-09-08] Colgate-Palmolive signs on to AI tool for biomaterials development (Packaging Dive)
*   **Neutral/General Market:**
    *   [2025-09-07] Here’s what you would need to know about the equity market this summer (Investing.com)
    *   [2025-09-06] Trump, Fed, Russia and more: BCA offers 5 tactical views (Investing.com)
    *   [2025-09-04] Exports rise, imports fall: Canada’s trade deficit shrinks to $4.9 billion (Investing.com)
    *   [2025-09-04] Trump urges Putin-Zelenskiy meeting, tells Europe to stop buying Russian oil (Investing.com)

*   **Analysis:** The news is mixed. The passive income article could attract some investors, and the AI partnership suggests innovation. However, there are broader market and political news items that could impact the stock indirectly.

**4-2) Analyst Opinions**

*   **Consensus:**
    *   Rating: Buy (Mean = 2.10)
    *   Opinions: 18
    *   Target Price: 95.22 (Avg) / 106.00 (High) / 83.00 (Low)
*   **Recent Rating Changes:** No changes indicated.

*   **Analysis:** Analysts are generally positive on CL, with a consensus rating of "Buy" and an average target price significantly above the current price. However, it's important to note the low target price is *below* the current price.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue  |
| :---------- | :--- | :------- |
| 2025-08-01 | 0.92 | $5.11B  |
| 2025-04-25 | 0.85 | $4.91B  |
| 2024-10-25 | 0.90 | $5.03B  |
| 2024-07-26 | 0.89 | $5.06B  |
| 2025-08-01 | 0.89 | $5.06B  |

*   **Analysis:**  Earnings and revenue have been relatively stable. Recent EPS is showing positive sign.

**6) Financial Information**

| Quarter    | Revenue   | Profit Margin |
| :---------- | :-------- | :------------- |
| 2025-06-30 | $5.11B    | 60.06%        |
| 2025-03-31 | $4.91B    | 60.82%        |
| 2024-12-31 | $4.95B    | 60.30%        |
| 2024-09-30 | $5.03B    | 61.08%        |
| 2024-06-30 | $5.06B    | 60.62%        |

| Quarter    | Equity   | ROE       |
| :---------- | :------- | :-------- |
| 2025-06-30 | $0.70B    | 105.84%   |
| 2025-03-31 | $0.36B    | 190.08%   |
| 2024-12-31 | $0.21B    | 348.58%   |
| 2024-09-30 | $0.43B    | 169.43%   |
| 2024-06-30 | $0.12B    | 594.31%   |

*   **Analysis:** Revenue is consistent, and profit margins are very high and stable.  However, ROE fluctuates dramatically, likely due to changes in equity. This warrants further investigation to understand the drivers behind the equity changes.

**7) 종합 Analysis**

Colgate-Palmolive (CL) presents a mixed picture. While it's a stable consumer staples company with consistent revenue, high profit margins, and analyst "Buy" ratings, several factors raise concerns:

*   **Underperformance:** Significant underperformance compared to the S&P 500, and negative Alpha in recent periods.
*   **Technical Indicators:** Recent price decline, RSI indicating potential for further downside,
*   **Expected Return:** The extremely negative expected return is a major red flag.
*    **Fluctuating ROE:** ROE fluctuations, driven by changes in Equity, need further investigation.

**Conclusion:**

While CL might be considered a safe, dividend-paying stock, the current data suggests potential issues with its growth prospects and ability to generate returns compared to the overall market. The negative expected return is particularly alarming. A deeper dive into the reasons for the underperformance, ROE fluctuations, and the drivers behind the negative expected return is warranted before making any investment decisions.
